However, bupropion may inhibit cytochrome P450 2D6 (CYP2D6), thereby increasing plasma concentrations of SSRIs [12-14]. Naltrexone, an opioid receptor antagonist commonly used for alcohol and opioid dependence, is not traditionally associated with serotonergic activity. This evidence concerns the gene CYP2D6 and opiate dependence.